Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone801-214-7800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Myrexis (OTCMKTS:MYRX) Frequently Asked Questions
What is Myrexis' stock symbol?
Myrexis trades on the OTCMKTS under the ticker symbol "MYRX."
Has Myrexis been receiving favorable news coverage?
Media stories about MYRX stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Myrexis earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term.
Who are some of Myrexis' key competitors?
Some companies that are related to Myrexis include Parnell Pharmaceuticals (PARNF), Propanc Biopharma (PPCB), Acura Pharmaceuticals (ACUR), ContraVir Pharmaceuticals (CTRV), Bioblast Pharma (ORPN), Integrated BioPharma (INBP), Midatech Pharma (MTP), Ritter Pharmaceuticals (RTTR), iCo Therapeutics (ICOTF), Mabvax Therapeutics (MBVX), Tonix Pharmaceuticals (TNXP), American Bio Medica (ABMC), Global Future City (FTCY), Anthera Pharmaceuticals (ANTH) and Respirerx Pharmaceuticals (RSPI).
Who are Myrexis' key executives?
Myrexis' management team includes the folowing people:
- Mr. Jonathan M. Couchman, Chairman, CEO, Pres, CFO and Principal Accounting Officer (Age 49)
How do I buy shares of Myrexis?
Shares of MYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Myrexis' stock price today?
One share of MYRX stock can currently be purchased for approximately $0.0350.
How big of a company is Myrexis?
Myrexis has a market capitalization of $1.21 million.
What is Myrexis' official website?
How can I contact Myrexis?
Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected]
MarketBeat Community Rating for Myrexis (OTCMKTS MYRX)
MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe MYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
